Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats.
about
Studies of Immune Responses in Candida vaginitisCytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarminsAdaptive immunity to fungiCandida albicans possesses Sap7 as a pepstatin A-insensitive secreted aspartic proteaseIn vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida speciesPotential role for a carbohydrate moiety in anti-Candida activity of human oral epithelial cells.Measurement of T-cell-derived antigen binding molecules and immunoglobulin G specific to Candida albicans mannan in sera of patients with recurrent vulvovaginal candidiasis.A 70-kilodalton recombinant heat shock protein of Candida albicans is highly immunogenic and enhances systemic murine candidiasis.Candida infections and their prevention.High aspartyl proteinase production and vaginitis in human immunodeficiency virus-infected womenSpecificity and prevalence of natural bovine antimannan antibodies.Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis.Analysis of vaginal cell populations during experimental vaginal candidiasis.Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicansIntravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasisImmune cell-mediated protection against vaginal candidiasis: evidence for a major role of vaginal CD4(+) T cells and possible participation of other local lymphocyte effectors.Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.Candida-specific antibodies during experimental vaginal candidiasis in mice.Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis.Vaginal and oral epithelial cell anti-Candida activityA fungicidal monoclonal antibody protects against murine invasive candidiasis.Prospects for development of a vaccine to prevent and control vaginal candidiasis.Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis.The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium.Candida albicans secreted aspartyl proteinases in virulence and pathogenesisVaccine and monoclonal antibody that enhance mouse resistance to candidiasisSecretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice.A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities.Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.Anticandidal immunity and vaginitis: novel opportunities for immune intervention.Adaptive immune responses to Candida albicans infection.New approaches in the development of a vaccine for mucosal candidiasis: progress and challengesA novel glyco-conjugate vaccine against fungal pathogens.Advances in combating fungal diseases: vaccines on the thresholdSynthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis.Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma.NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response.Efficient diagnosis of vulvovaginal candidiasis by use of a new rapid immunochromatography test.Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases.Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients.
P2860
Q26782272-024CCA7C-81EA-4F97-9775-AFC23D35C1BCQ27021956-79440E45-9878-45AC-A0BD-55B4094CDD4CQ27025806-C9AEC1BD-5C30-442C-A23E-33CF548D2D5AQ28481265-93023726-5D09-4A8D-BE42-E5FA18E6814AQ33262661-3EF54E7A-EB4C-49D0-BAAC-89044374BF6DQ33553682-31A996F5-2DCE-4946-8E36-1C143C49574DQ33595842-C9E3F3B9-7BD0-4DC1-97AC-361F79CE6AC3Q33753864-06E5C5F5-9D4F-4F43-8643-E26EA18BF59EQ33775256-0E23E633-737F-419A-91ED-14A3718A5974Q33960136-90888D0E-89F1-445F-89AD-8B255B09CF58Q33998047-30FBC912-7144-4AEB-A77F-53BB34BE1713Q34000362-4ACFDD0E-C4DE-41FE-9B25-2402AEA73D7EQ34001275-2949F914-7789-4FBD-B95B-2990C6E19F39Q34004652-7E556766-A7B9-4885-85A1-EBA2A9A39BBDQ34121150-CB845B2A-B07D-449E-8115-4A45F2752E5BQ34130381-AFF0B961-6130-4616-8D85-9B7D01AD2593Q34131697-9B959748-1FFF-4EFD-AD4F-2738133814C3Q34131799-1AF7290C-95F8-44B6-B689-89469702F5D8Q34259665-33ECD007-BA48-421F-A4DD-1086900B5D71Q34261507-AAF0A5C8-55B7-4C72-9599-4479532A03A8Q34601994-ABCF09C5-EEC6-4407-A49C-01047BC93CB1Q34707478-5EAB9F26-B9A9-46FB-B2C3-3473886F23D7Q34720954-F57C6893-79DB-46F5-954A-3DBB6E9D638FQ35012319-F73E149E-1A22-4E4E-8A61-FF2A199D212FQ35215948-31602836-B03F-4165-BEC8-3D74F6185D21Q35271053-FAC28AA3-5921-40B5-9677-ED1C3CC54A4CQ35650359-FBD5F0BF-1766-498D-B257-FBB492E5C1C7Q35802339-CCD650D2-2116-4FE0-8D16-D1ED1EF28A47Q35920633-C805CB60-A884-4F59-8E22-36088D05C414Q36097307-BD71510C-3CE4-4701-AF4A-46B12D4915E4Q36147114-A0C14FEB-1BD9-457C-9498-419C8C0FE5CBQ36158337-98FF24CA-0366-4332-953E-9D1E50FD5A24Q36402820-E1B56910-AE8A-4473-A9D6-6CE16FA98C06Q36406460-C52F0E81-C685-48F6-A977-867CFF0865A3Q36869958-D8660E77-EBFC-4CC5-A5EA-C9FA9F3233A0Q36914682-F402A2F4-21FB-4A1D-8322-C221A2EF955DQ37399422-2245A13B-7B56-4711-9FDC-F99ACA9056A8Q37451649-0443F5FA-83D4-4FBC-8814-E53C9C85D0C1Q38011299-C5816377-3F2D-4E56-9C4F-636192690C47Q39471544-058DE373-8A0B-4142-83FF-90F970F5B36B
P2860
Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats.
description
1997 nî lūn-bûn
@nan
1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Protective role of antimannan ...... da albicans vaginitis in rats.
@ast
Protective role of antimannan ...... da albicans vaginitis in rats.
@en
type
label
Protective role of antimannan ...... da albicans vaginitis in rats.
@ast
Protective role of antimannan ...... da albicans vaginitis in rats.
@en
prefLabel
Protective role of antimannan ...... da albicans vaginitis in rats.
@ast
Protective role of antimannan ...... da albicans vaginitis in rats.
@en
P2093
P2860
P1476
Protective role of antimannan ...... da albicans vaginitis in rats.
@en
P2093
Boccanera M
De Bernardis F
Spreghini E
P2860
P304
P407
P577
1997-08-01T00:00:00Z